Global Dengue Fever Treatment Market Insights, Forecast to 2034
Global Dengue Fever Treatment market is expected to reach to US$ 151 million in 2024, with a positive growth of %, compared with US$ 137 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Dengue Fever Treatment industry is evaluated to reach US$ 155.6 million in 2029. The CAGR will be 0.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Dengue Fever Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Dengue Fever Treatment market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Fresenius Kabi USA
Sun Pharmaceutical Industries
Mylan N.V
Pfizer
Teva Pharmaceuticals USA
EMERGEX VACCINES
Hikma Pharmaceuticals
ABIVAX, Aurobindo Pharma
Baxter
Perrigo
GlaxoSmithKline
Dr. Reddy’s Laboratories
Sanofi
Takeda Pharmaceutical
Segment by Type
Drug
Vaccines
Segment by Application
Hospital
Homecare
Specialty Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Dengue Fever Treatment plant distribution, commercial date of Dengue Fever Treatment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Dengue Fever Treatment introduction, etc. Dengue Fever Treatment Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Dengue Fever Treatment
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Dengue Fever Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Dengue Fever Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Drug
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Dengue Fever Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dengue Fever Treatment Sales Estimates and Forecasts 2018-2029
2.2 Global Dengue Fever Treatment Revenue by Region
2.2.1 Global Dengue Fever Treatment Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Dengue Fever Treatment Revenue by Region (2018-2024)
2.2.3 Global Dengue Fever Treatment Revenue by Region (2024-2029)
2.2.4 Global Dengue Fever Treatment Revenue Market Share by Region (2018-2029)
2.3 Global Dengue Fever Treatment Sales Estimates and Forecasts 2018-2029
2.4 Global Dengue Fever Treatment Sales by Region
2.4.1 Global Dengue Fever Treatment Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Dengue Fever Treatment Sales by Region (2018-2024)
2.4.3 Global Dengue Fever Treatment Sales by Region (2024-2029)
2.4.4 Global Dengue Fever Treatment Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dengue Fever Treatment Sales by Manufacturers
3.1.1 Global Dengue Fever Treatment Sales by Manufacturers (2018-2024)
3.1.2 Global Dengue Fever Treatment Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dengue Fever Treatment in 2022
3.2 Global Dengue Fever Treatment Revenue by Manufacturers
3.2.1 Global Dengue Fever Treatment Revenue by Manufacturers (2018-2024)
3.2.2 Global Dengue Fever Treatment Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dengue Fever Treatment Revenue in 2022
3.3 Global Key Players of Dengue Fever Treatment, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Dengue Fever Treatment Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dengue Fever Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dengue Fever Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Dengue Fever Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dengue Fever Treatment Sales by Type
4.1.1 Global Dengue Fever Treatment Historical Sales by Type (2018-2024)
4.1.2 Global Dengue Fever Treatment Forecasted Sales by Type (2024-2029)
4.1.3 Global Dengue Fever Treatment Sales Market Share by Type (2018-2029)
4.2 Global Dengue Fever Treatment Revenue by Type
4.2.1 Global Dengue Fever Treatment Historical Revenue by Type (2018-2024)
4.2.2 Global Dengue Fever Treatment Forecasted Revenue by Type (2024-2029)
4.2.3 Global Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Dengue Fever Treatment Price by Type
4.3.1 Global Dengue Fever Treatment Price by Type (2018-2024)
4.3.2 Global Dengue Fever Treatment Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Dengue Fever Treatment Sales by Application
5.1.1 Global Dengue Fever Treatment Historical Sales by Application (2018-2024)
5.1.2 Global Dengue Fever Treatment Forecasted Sales by Application (2024-2029)
5.1.3 Global Dengue Fever Treatment Sales Market Share by Application (2018-2029)
5.2 Global Dengue Fever Treatment Revenue by Application
5.2.1 Global Dengue Fever Treatment Historical Revenue by Application (2018-2024)
5.2.2 Global Dengue Fever Treatment Forecasted Revenue by Application (2024-2029)
5.2.3 Global Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Dengue Fever Treatment Price by Application
5.3.1 Global Dengue Fever Treatment Price by Application (2018-2024)
5.3.2 Global Dengue Fever Treatment Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Dengue Fever Treatment Market Size by Type
6.1.1 US & Canada Dengue Fever Treatment Sales by Type (2018-2029)
6.1.2 US & Canada Dengue Fever Treatment Revenue by Type (2018-2029)
6.2 US & Canada Dengue Fever Treatment Market Size by Application
6.2.1 US & Canada Dengue Fever Treatment Sales by Application (2018-2029)
6.2.2 US & Canada Dengue Fever Treatment Revenue by Application (2018-2029)
6.3 US & Canada Dengue Fever Treatment Market Size by Country
6.3.1 US & Canada Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Dengue Fever Treatment Sales by Country (2018-2029)
6.3.3 US & Canada Dengue Fever Treatment Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dengue Fever Treatment Market Size by Type
7.1.1 Europe Dengue Fever Treatment Sales by Type (2018-2029)
7.1.2 Europe Dengue Fever Treatment Revenue by Type (2018-2029)
7.2 Europe Dengue Fever Treatment Market Size by Application
7.2.1 Europe Dengue Fever Treatment Sales by Application (2018-2029)
7.2.2 Europe Dengue Fever Treatment Revenue by Application (2018-2029)
7.3 Europe Dengue Fever Treatment Market Size by Country
7.3.1 Europe Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Dengue Fever Treatment Sales by Country (2018-2029)
7.3.3 Europe Dengue Fever Treatment Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dengue Fever Treatment Market Size
8.1.1 China Dengue Fever Treatment Sales (2018-2029)
8.1.2 China Dengue Fever Treatment Revenue (2018-2029)
8.2 China Dengue Fever Treatment Market Size by Application
8.2.1 China Dengue Fever Treatment Sales by Application (2018-2029)
8.2.2 China Dengue Fever Treatment Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Dengue Fever Treatment Market Size by Type
9.1.1 Asia Dengue Fever Treatment Sales by Type (2018-2029)
9.1.2 Asia Dengue Fever Treatment Revenue by Type (2018-2029)
9.2 Asia Dengue Fever Treatment Market Size by Application
9.2.1 Asia Dengue Fever Treatment Sales by Application (2018-2029)
9.2.2 Asia Dengue Fever Treatment Revenue by Application (2018-2029)
9.3 Asia Dengue Fever Treatment Sales by Region
9.3.1 Asia Dengue Fever Treatment Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Dengue Fever Treatment Revenue by Region (2018-2029)
9.3.3 Asia Dengue Fever Treatment Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dengue Fever Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Dengue Fever Treatment Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Dengue Fever Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Dengue Fever Treatment Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Dengue Fever Treatment Sales by Country
10.3.1 Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Dengue Fever Treatment Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Fresenius Kabi USA
11.1.1 Fresenius Kabi USA Company Information
11.1.2 Fresenius Kabi USA Overview
11.1.3 Fresenius Kabi USA Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Fresenius Kabi USA Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Fresenius Kabi USA Recent Developments
11.2 Sun Pharmaceutical Industries
11.2.1 Sun Pharmaceutical Industries Company Information
11.2.2 Sun Pharmaceutical Industries Overview
11.2.3 Sun Pharmaceutical Industries Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Industries Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Industries Recent Developments
11.3 Mylan N.V
11.3.1 Mylan N.V Company Information
11.3.2 Mylan N.V Overview
11.3.3 Mylan N.V Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Mylan N.V Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan N.V Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Teva Pharmaceuticals USA
11.5.1 Teva Pharmaceuticals USA Company Information
11.5.2 Teva Pharmaceuticals USA Overview
11.5.3 Teva Pharmaceuticals USA Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Teva Pharmaceuticals USA Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceuticals USA Recent Developments
11.6 EMERGEX VACCINES
11.6.1 EMERGEX VACCINES Company Information
11.6.2 EMERGEX VACCINES Overview
11.6.3 EMERGEX VACCINES Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 EMERGEX VACCINES Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 EMERGEX VACCINES Recent Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Information
11.7.2 Hikma Pharmaceuticals Overview
11.7.3 Hikma Pharmaceuticals Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hikma Pharmaceuticals Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Pharmaceuticals Recent Developments
11.8 ABIVAX, Aurobindo Pharma
11.8.1 ABIVAX, Aurobindo Pharma Company Information
11.8.2 ABIVAX, Aurobindo Pharma Overview
11.8.3 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ABIVAX, Aurobindo Pharma Recent Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Overview
11.9.3 Baxter Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Baxter Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxter Recent Developments
11.10 Perrigo
11.10.1 Perrigo Company Information
11.10.2 Perrigo Overview
11.10.3 Perrigo Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Perrigo Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Perrigo Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Overview
11.11.3 GlaxoSmithKline Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 GlaxoSmithKline Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline Recent Developments
11.12 Dr. Reddy’s Laboratories
11.12.1 Dr. Reddy’s Laboratories Company Information
11.12.2 Dr. Reddy’s Laboratories Overview
11.12.3 Dr. Reddy’s Laboratories Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Dr. Reddy’s Laboratories Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dr. Reddy’s Laboratories Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Sanofi Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Takeda Pharmaceutical
11.14.1 Takeda Pharmaceutical Company Information
11.14.2 Takeda Pharmaceutical Overview
11.14.3 Takeda Pharmaceutical Dengue Fever Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Takeda Pharmaceutical Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dengue Fever Treatment Industry Chain Analysis
12.2 Dengue Fever Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dengue Fever Treatment Production Mode & Process
12.4 Dengue Fever Treatment Sales and Marketing
12.4.1 Dengue Fever Treatment Sales Channels
12.4.2 Dengue Fever Treatment Distributors
12.5 Dengue Fever Treatment Customers
13 Market Dynamics
13.1 Dengue Fever Treatment Industry Trends
13.2 Dengue Fever Treatment Market Drivers
13.3 Dengue Fever Treatment Market Challenges
13.4 Dengue Fever Treatment Market Restraints
14 Key Findings in The Global Dengue Fever Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Dengue Fever Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Drug
Table 3. Major Manufacturers of Vaccines
Table 4. Global Dengue Fever Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Dengue Fever Treatment Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Dengue Fever Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Dengue Fever Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Dengue Fever Treatment Revenue Market Share by Region (2018-2024)
Table 9. Global Dengue Fever Treatment Revenue Market Share by Region (2024-2029)
Table 10. Global Dengue Fever Treatment Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Dengue Fever Treatment Sales by Region (2018-2024) & (K Units)
Table 12. Global Dengue Fever Treatment Sales by Region (2024-2029) & (K Units)
Table 13. Global Dengue Fever Treatment Sales Market Share by Region (2018-2024)
Table 14. Global Dengue Fever Treatment Sales Market Share by Region (2024-2029)
Table 15. Global Dengue Fever Treatment Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Dengue Fever Treatment Sales Share by Manufacturers (2018-2024)
Table 17. Global Dengue Fever Treatment Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Dengue Fever Treatment Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Dengue Fever Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Dengue Fever Treatment Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Dengue Fever Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Dengue Fever Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Fever Treatment as of 2022)
Table 23. Global Key Manufacturers of Dengue Fever Treatment, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Dengue Fever Treatment, Product Offered and Application
Table 25. Global Key Manufacturers of Dengue Fever Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 28. Global Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 29. Global Dengue Fever Treatment Sales Share by Type (2018-2024)
Table 30. Global Dengue Fever Treatment Sales Share by Type (2024-2029)
Table 31. Global Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Dengue Fever Treatment Revenue Share by Type (2018-2024)
Table 34. Global Dengue Fever Treatment Revenue Share by Type (2024-2029)
Table 35. Dengue Fever Treatment Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Dengue Fever Treatment Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 38. Global Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 39. Global Dengue Fever Treatment Sales Share by Application (2018-2024)
Table 40. Global Dengue Fever Treatment Sales Share by Application (2024-2029)
Table 41. Global Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Dengue Fever Treatment Revenue Share by Application (2018-2024)
Table 44. Global Dengue Fever Treatment Revenue Share by Application (2024-2029)
Table 45. Dengue Fever Treatment Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Dengue Fever Treatment Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Dengue Fever Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 60. Europe Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 61. Europe Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 62. Europe Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 65. Europe Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 66. Europe Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Dengue Fever Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 72. Europe Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 73. China Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 74. China Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 75. China Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 78. China Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 79. China Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 82. Asia Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 83. Asia Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 86. Asia Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 87. Asia Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Dengue Fever Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Dengue Fever Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Dengue Fever Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Dengue Fever Treatment Sales by Region (2018-2024) & (K Units)
Table 93. Asia Dengue Fever Treatment Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dengue Fever Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Dengue Fever Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Dengue Fever Treatment Sales by Country (2024-2029) & (K Units)
Table 107. Fresenius Kabi USA Company Information
Table 108. Fresenius Kabi USA Description and Major Businesses
Table 109. Fresenius Kabi USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Fresenius Kabi USA Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Fresenius Kabi USA Recent Developments
Table 112. Sun Pharmaceutical Industries Company Information
Table 113. Sun Pharmaceutical Industries Description and Major Businesses
Table 114. Sun Pharmaceutical Industries Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sun Pharmaceutical Industries Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sun Pharmaceutical Industries Recent Developments
Table 117. Mylan N.V Company Information
Table 118. Mylan N.V Description and Major Businesses
Table 119. Mylan N.V Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Mylan N.V Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mylan N.V Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Teva Pharmaceuticals USA Company Information
Table 128. Teva Pharmaceuticals USA Description and Major Businesses
Table 129. Teva Pharmaceuticals USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Teva Pharmaceuticals USA Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Teva Pharmaceuticals USA Recent Developments
Table 132. EMERGEX VACCINES Company Information
Table 133. EMERGEX VACCINES Description and Major Businesses
Table 134. EMERGEX VACCINES Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. EMERGEX VACCINES Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. EMERGEX VACCINES Recent Developments
Table 137. Hikma Pharmaceuticals Company Information
Table 138. Hikma Pharmaceuticals Description and Major Businesses
Table 139. Hikma Pharmaceuticals Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Hikma Pharmaceuticals Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hikma Pharmaceuticals Recent Developments
Table 142. ABIVAX, Aurobindo Pharma Company Information
Table 143. ABIVAX, Aurobindo Pharma Description and Major Businesses
Table 144. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. ABIVAX, Aurobindo Pharma Recent Developments
Table 147. Baxter Company Information
Table 148. Baxter Description and Major Businesses
Table 149. Baxter Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Baxter Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Baxter Recent Developments
Table 152. Perrigo Company Information
Table 153. Perrigo Description and Major Businesses
Table 154. Perrigo Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Perrigo Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Perrigo Recent Developments
Table 157. GlaxoSmithKline Company Information
Table 158. GlaxoSmithKline Description and Major Businesses
Table 159. GlaxoSmithKline Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. GlaxoSmithKline Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. GlaxoSmithKline Recent Developments
Table 162. Dr. Reddy’s Laboratories Company Information
Table 163. Dr. Reddy’s Laboratories Description and Major Businesses
Table 164. Dr. Reddy’s Laboratories Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Dr. Reddy’s Laboratories Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Dr. Reddy’s Laboratories Recent Developments
Table 167. Sanofi Company Information
Table 168. Sanofi Description and Major Businesses
Table 169. Sanofi Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Sanofi Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Sanofi Recent Developments
Table 172. Takeda Pharmaceutical Company Information
Table 173. Takeda Pharmaceutical Description and Major Businesses
Table 174. Takeda Pharmaceutical Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Takeda Pharmaceutical Dengue Fever Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Takeda Pharmaceutical Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Dengue Fever Treatment Distributors List
Table 180. Dengue Fever Treatment Customers List
Table 181. Dengue Fever Treatment Market Trends
Table 182. Dengue Fever Treatment Market Drivers
Table 183. Dengue Fever Treatment Market Challenges
Table 184. Dengue Fever Treatment Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Dengue Fever Treatment Product Picture
Figure 2. Global Dengue Fever Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dengue Fever Treatment Market Share by Type in 2022 & 2029
Figure 4. Drug Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global Dengue Fever Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Dengue Fever Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Homecare
Figure 10. Specialty Clinics
Figure 11. Others
Figure 12. Dengue Fever Treatment Report Years Considered
Figure 13. Global Dengue Fever Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Dengue Fever Treatment Revenue 2018-2029 (US$ Million)
Figure 15. Global Dengue Fever Treatment Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Dengue Fever Treatment Revenue Market Share by Region (2018-2029)
Figure 17. Global Dengue Fever Treatment Sales 2018-2029 ((K Units)
Figure 18. Global Dengue Fever Treatment Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Dengue Fever Treatment Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Dengue Fever Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Dengue Fever Treatment Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Dengue Fever Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Dengue Fever Treatment Sales YoY (2018-2029) & (K Units)
Figure 24. China Dengue Fever Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Dengue Fever Treatment Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Dengue Fever Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Dengue Fever Treatment Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Dengue Fever Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Dengue Fever Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Dengue Fever Treatment in the World: Market Share by Dengue Fever Treatment Revenue in 2022
Figure 31. Global Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 33. Global Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 34. Global Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 35. Global Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Dengue Fever Treatment Revenue Share by Country (2018-2029)
Figure 41. US & Canada Dengue Fever Treatment Sales Share by Country (2018-2029)
Figure 42. U.S. Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 45. Europe Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 46. Europe Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 47. Europe Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 48. Europe Dengue Fever Treatment Revenue Share by Country (2018-2029)
Figure 49. Europe Dengue Fever Treatment Sales Share by Country (2018-2029)
Figure 50. Germany Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 51. France Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 55. China Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 56. China Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 57. China Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 58. China Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 59. Asia Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 60. Asia Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 61. Asia Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 62. Asia Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 63. Asia Dengue Fever Treatment Revenue Share by Region (2018-2029)
Figure 64. Asia Dengue Fever Treatment Sales Share by Region (2018-2029)
Figure 65. Japan Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 69. India Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Dengue Fever Treatment Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Dengue Fever Treatment Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Dengue Fever Treatment Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Dengue Fever Treatment Sales Share by Country (2018-2029)
Figure 76. Brazil Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Dengue Fever Treatment Revenue (2018-2029) & (US$ Million)
Figure 81. Dengue Fever Treatment Value Chain
Figure 82. Dengue Fever Treatment Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices